BREAKING NEWS: New drug approved by the FDA for Duchenne muscular dystrophy. Learn more about this new treatment option.

Medical Educational Resource

We're accelerating the delivery of treatments and cures.

Best Practices for Optimizing Patient Care and Access to Treatment

Activity Snapshot

Activity Type: 
On-Demand Webinar
Release Date: 
Monday, March 8, 2021
Expiration Date: 
Tuesday, March 8, 2022
Sponsor Information: 

This program is supported in part by an independent medical education grant from Biogen and Mitsubishi Tanabe Pharma America, Inc.

Faculty

Elizabeth Kichula, MD, PhD
Pediatric Neurologist
Children's Hospital of Pennsylvania
Jinsy A. Andrews, MD, MSc, FAAN
Director of Neuromuscular Clinical Trials
Columbia University Irving Medical Center
Activity Overview: 

Elizabeth Kichula from Children’s Hospital of Philadelphia and Jinsy Andrews from Columbia University Irving Medical Center provide an overview of best practices and learnings that optimize patient access to care and support more efficient and effective access to treatments. The webinar reviews barriers that obstruct access to pediatric and adult care, highlights the critical role of the clinical care coordinator in optimizing treatment access, and presents best practice information to help improve patient access to treatment.

Learning Objectives: 
  • Identify insights and learnings from centers of excellence and MDA Care Centers to address the changing landscape of processes, logistics, and staffing considerations in order to best optimize patient access to care
  •  Address critical role of Clinical Care Coordinators as the linchpins of patient access and support, including best practices to optimize this role within a practice​
  • Present specific best practices and learnings that support more efficient and effective access to treatments
Accreditation and Designation Statement: 

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of PeerPoint Medical Education Institute, LLC and the Muscular Dystrophy Association. The PeerPoint Medical Education Institute, LLC is accredited by the ACCME to provide continuing medical education for physicians.

The PeerPoint Medical Education Institute, LLC designates this enduring activity for a maximum of .5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Dates: March 8, 2021 – March 8, 2022

How to Obtain CME credits : 

Once you have viewed the program, MDA will share back with you instructions for how to obtain your CME credits. If you have questions on this process, please reach out to cmemanagement@mdausa.org.

Faculty Disclosures: 

The following presenters, planners, editors, or staff have relevant financial relationships to disclose:

"I, have at present or have had within the last 12 months, the following affiliation with one or more organizations that could be perceived as a real or apparent conflict of interest in context to the design, implementation, presentation, evaluation, etc. of CME Activities.”

Name: Elizabeth Kichula, MD
Commercial Interest: Genentech
What role?: Speaker's Bureau
What was received: Consulting fee

Name: Elizabeth Kichula, MD
Commercial Interest: Avexis
What role?: Advisory Board
What was received: Consulting fee

Name: Elizabeth Kichula, MD
Commercial Interest: Natera
What role?: Speaking arrangement
What was received: Consulting fee

Name: Elizabeth Kichula, MD
Commercial Interest: BCBS
What role?: Advisory Board
What was received: Consulting fee

Name: Elizabeth Kichula, MD
Commercial Interest: Biogen
What role?: Advisory board and consulting
What was received: Consulting fee

Name: Jinsy Andrews, MD
Commercial Interest: AL-S Pharma
What role?: DSMB Member
What was received: Consulting fee

Name: Jinsy Andrews, MD
Commercial Interest: Biogen
What role?: Steering Committee
What was received: Consulting fee

Name: Jinsy Andrews, MD
Commercial Interest: Cytokinetics
What role?: Steering Committee
What was received: Consulting fee

Name: Jinsy Andrews, MD
Commercial Interest: Wave
What role?: Consulting
What was received: Consulting fee